MetaCap

AEON Biopharma (AEON) vs Optimi Health (OPTH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

AEON Biopharma is the larger company by market cap ($10.3 million vs $8.6 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AEON-85.75%OPTH-75.16%
+4%-43%-91%
May 20, 20261 yearNov 20, 2026
AEON-84.17%OPTH-74.19%
+6%-41%-88%
May 18, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AEON versus OPTH key metrics
MetricAEONOPTH
Share price$0.123$1.51
Market cap$10.35M$8.65M
1-day change-7.59%-13.71%
YTD return-88.82%—
1-year return-85.18%—
EPS (TTM)$-3.89$-1.56
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-39.22M—
52-week high$1.45$6.40
52-week low$0.106$1.51
Distance from 52-week high-91.52%-76.41%
Analyst consensusstrong_buy—
Avg. price target upside+1379.67%—
Average volume7.44M43.55K
Shares outstanding84.12M5.73M
Employees8—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About AEON Biopharma

AEON stock →

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine.

Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees

About Optimi Health

OPTH stock →

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations

AEON vs OPTH FAQ

Which is bigger, AEON Biopharma or Optimi Health?

AEON Biopharma (AEON) is larger, with a market capitalization of $10.35M compared with $8.65M for Optimi Health (OPTH).

Are AEON Biopharma and Optimi Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons